Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06600893
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-14
Brief Title:
Sham-Controlled Prospective Study Characterizing Erectile Tissue Ultrasound Changes Resulting From Penile LiSWT
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Single-Blind Sham-Controlled Randomized Prospective Study Characterizing Erectile Tissue Ultrasound Changes Resulting From Low Intensity Penile Shockwave Treatment With Urogold 100
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary goal of this single blind prospective sham-controlled clinical trial is to assess safety and efficacy of low intensity shockwave therapy LiSWT to improve erectile function in men 21-80 years of age with erectile dysfunction naive to radial ballistic acoustic wave and LiSWT The main questions it aims to answer are
Does homogeneityinhomogeneity of corporal cavernosal tissue improve using Grayscale ultrasound GUS when comparing sham to active treatment groups
Do peak systolic velocity PSV and end diastolic velocity EDV improve using color duplex Doppler ultrasound when comparing sham to active treatment groups
Do the International Index of Erectile Function IIEF its erectile function domain IIEF-EF and question 3 of the Sexual Encounter Profile SEP improve comparing sham to active treatment groups
Does homogeneityinhomogeneity of corporal cavernosal tissue improve using Grayscale ultrasound GUS when comparing sham to active treatment groups
Do peak systolic velocity PSV and end diastolic velocity EDV improve using color duplex Doppler ultrasound when comparing sham to active treatment groups
Do the International Index of Erectile Function IIEF its erectile function domain IIEF-EF and question 3 of the Sexual Encounter Profile SEP improve comparing sham to active treatment groups
Detailed Description:
This is a single site sham-controlled clinical trial to be conducted at San Diego Sexual Medicine in San Diego California Subjects meeting inclusion and exclusion criteria will be randomized to one of two arms each 21 active to sham treated in 3-week cycles Arm 1 consists of 5000 shocks the first week and two weeks off for each of three treatment cycles Arm 2 is made up of 5000 shocks the first week and 3000 active shocks the second and third weeks followed by three weeks without treatment and then 5000 3000 and 3000 shocks again over the next three weeks Each of these is followed by the first follow-up visit at 20 weeks after the first treatment when GUS and DUS is repeated and validated instruments completed at which time treatment will be unblinded SEP diaries will be completed during sexual activity in the screening period and during the 4 weeks prior to the follow up visit Those subjects assigned to sham will be crossed over to the opposite arm for active treatment arm 1 sham goes to arm 2 open label and arm 2 sham to arm 1 open label and begin active treatment with decreased intervals between shocks and therefore decreased number of shocks needed with 3500 rather than 5000 shocks and 2000 rather than 3000 shocks at a lower frequency at that visit after completing the follow up procedures Subjects assigned initially to the active arm will have a second follow up 32 weeks after the first treatment and complete SEP diaries during the 4 weeks preceding this visit GUS and DUS is performed and validated instruments completed at the last follow up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None